SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR

1086 reported adverse events

Drug classes: Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] Hepatitis C Virus NS5A Inhibitor [EPC] Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]

These side effects are most commonly reported by patients taking SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR:

# Side effect Count
0 FATIGUE 197
1 HEADACHE 134
2 TREATMENT FAILURE 115
3 DRUG INEFFECTIVE 108
4 NAUSEA 104
5 HEPATITIS C 91
6 DIARRHOEA 86
7 VOMITING 36
8 INSOMNIA 29
9 ABDOMINAL DISCOMFORT 23
See all common reactions for SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR

SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THERMAL ABLATION 2 0.1538
1 ALLOIMMUNE HEPATITIS 1 0.1429
2 ANORECTAL VARICES HAEMORRHAGE 1 0.0312
3 HEPATITIS C RNA POSITIVE 5 0.0292
4 CHILD-PUGH-TURCOTTE SCORE INCREASED 2 0.0235
5 EYE INFECTION SYPHILITIC 1 0.0213
6 HEPATITIS C VIRUS TEST POSITIVE 12 0.0204
7 ELEPHANTIASIS 1 0.0149
8 GENOTYPE DRUG RESISTANCE TEST POSITIVE 11 0.0107
9 ANAL EROSION 1 0.0091
See all enriched reactions for SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR